EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vancomycin‐Modified DNA Origami Nanostructures for Targeting Bacterial Pathogens

Özge Coşkuner Leineweber, Bhanu K. Pothineni, Nils Schumann, Ulrike Hofmann, Christin Möser, David M. Smith, Guido Grundmeier, Yixin Zhang, Adrian Keller

Small Structures · 2025-12 · 6 (12)

DOI: 10.1002/sstr.202500246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small Structures, online erschienen am 21.08.2025. Verfasst von Özge Coşkuner Leineweber und 8 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The specific binding of DNA origami nanostructures (DONs) to bacteria is an important prerequisite for their application in pathogen targeting and antimicrobial drug delivery. So far, targeting bacteria with DONs has been achieved exclusively via aptamers, which suffer from drawbacks such as sensitivity toward environmental conditions and reduced binding after immobilization or conjugation. Here, an alternative approach is presented based on the modification of DONs with the cell wall‐binding glycopeptide antibiotic vancomycin. Using strain‐promoted azide‐alkyne cycloaddition, azide‐modified vancomycin is conjugated to selected staple strands and subsequently incorporated into 2D DON triangles. The resulting constructs show specific binding to the Gram‐positive species Bacillus subtilis ( B. subtilis ) and Staphylococcus capitis ( S. capitis ), and remarkably, to Gram‐negative Escherichia coli ( E. coli ), but no antimicrobial activity at vancomycin concentrations up to at least 2.91 μM. For B. subtilis and E. coli , DONs with vancomycin modifications on both sides exhibit better binding than DONs modified on only one side. However, both variants bind equally well to S. capitis . These results demonstrate the great potential of small molecule drug compounds for the robust, broad‐spectrum targeting of bacteria with DONs. Targeting a ubiquitous cell wall component of most pathogenic bacteria, vancomycin‐modified DONs have many potential applications in the prevention and treatment of nosocomial infections.

Zitieren

APA

Leineweber, Ö. C., Pothineni, B. K., Schumann, N., Hofmann, U., Möser, C., Smith, D. M., Grundmeier, G., Zhang, Y., & Keller, A. (2025). Vancomycin‐Modified DNA Origami Nanostructures for Targeting Bacterial Pathogens. Small Structures, 6(12). https://doi.org/10.1002/sstr.202500246

Vancouver

Leineweber ÖC, Pothineni BK, Schumann N, Hofmann U, Möser C, Smith DM, et al. Vancomycin‐Modified DNA Origami Nanostructures for Targeting Bacterial Pathogens. Small Structures. 2025;6(12). doi:10.1002/sstr.202500246

BibTeX
@article{Leineweber2025,
  author = {Leineweber, Özge Coşkuner and Pothineni, Bhanu K. and Schumann, Nils and Hofmann, Ulrike and Möser, Christin and Smith, David M. and Grundmeier, Guido and Zhang, Yixin and Keller, Adrian},
  title = {Vancomycin‐Modified DNA Origami Nanostructures for Targeting Bacterial Pathogens},
  journal = {Small Structures},
  year = {2025},
  volume = {6},
  number = {12},
  doi = {10.1002/sstr.202500246}
}
Kostenlos starten →